Medican Enterprises, Inc. Stock Other OTC
Equities
MDCN
US58464T2024
Pharmaceuticals
Financials (USD)
Sales 2013 | - | Sales 2014 | - | Capitalization | 660K |
---|---|---|---|---|---|
Net income 2013 | - | Net income 2014 | -56M | EV / Sales 2013 | - |
Net Debt 2013 | 117K | Net Debt 2014 | 5.85M | EV / Sales 2014 | - |
P/E ratio 2013 |
-21.9
x | P/E ratio 2014 |
-0.01
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Xavier
CEO | Chief Executive Officer | - | - |
Kenneth Williams
CHM | Chairman | 52 | 13-06-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kenneth Williams
CHM | Chairman | 52 | 13-06-24 |
1st Jan change | Capi. | |
---|---|---|
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |